Stocktoria
InspireMD, Inc. NSPR
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-04-12
InspireMD, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | $4.5M |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M | $754,000 |
| R&D expense | $15.0M | $13.6M | $8.0M | $7.8M | $5.2M |
| Operating income | -$49.6M | -$33.5M | -$21.1M | -$18.7M | -$14.7M |
| Income tax | $63,000 | $59,000 | $65,000 | $28,000 | $45,000 |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M | -$14.9M |
| EPS (diluted) | $-0.76 | $-0.76 | $-0.82 | $-2.35 | — |
| Operating cash flow | -$35.1M | -$21.9M | -$16.4M | -$15.5M | -$13.2M |
| Free cash flow | -$36.8M | -$23.3M | -$16.8M | -$16.0M | -$13.6M |
| Cash & equivalents | $8.9M | $18.9M | $9.6M | $4.6M | $12.0M |
| Inventory | $3.4M | $2.6M | $2.1M | $1.6M | $1.1M |
| Total assets | $69.4M | $46.8M | $47.6M | $24.7M | $39.7M |
| Total liabilities | $14.2M | $10.7M | $8.1M | $7.3M | $6.2M |
| Shareholders' equity | $55.2M | $36.1M | $39.5M | $17.4M | $33.5M |
Source: SEC EDGAR filings · CIK 0001433607 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.